aluates Reports

$ 0.0

Automative

Global Non-invasive Parenteral Screening Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-39C854

Global Non invasive Parenteral Screening Market Insights and Forecast to 2028

BUY CHAPTERS

Global Non-invasive Parenteral Screening Market Insights, Forecast to 2030

Code: QYRE-Auto-39C854

Report

December 2024

Pages:112

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GE Healthcare

Philips

Illumina Inc

Thermo Fisher Scientific

Roche

PacBio

PerkinElmer Inc

BGI Group

Qiagen

Qiagen NV

Agilent Technologies

Non-invasive Parenteral Screening Market Size

The global Non-invasive Parenteral Screening market is projected to grow from US$ 4178 million in 2024 to US$ 7241.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.6% during the forecast period.

Non-invasive Parenteral Screening Market

Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.

Market Analysis and Insights: Global Non-invasive Parenteral Screening Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Non-invasive Parenteral Screening market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Non-invasive Parenteral Screening, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-invasive Parenteral Screening, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-invasive Parenteral Screening revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Non-invasive Parenteral Screening market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Non-invasive Parenteral Screening revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Non-invasive Parenteral Screening Market Report

Report Metric	Details
Report Name	Non-invasive Parenteral Screening Market
Accounted market size in 2024	US$ 4178 million
Forecasted market size in 2030	US$ 7241.6 million
CAGR	9.6
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Instruments Consumables
Segment by Application	Diagnostic Laboratories Hospitals
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Non-invasive Parenteral Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive Parenteral Screening companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-invasive Parenteral Screening revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Non-invasive Parenteral Screening Market growing?

Ans: The Non-invasive Parenteral Screening Market witnessing a CAGR of 9.6 during the forecast period 2025-2030.

What is the Non-invasive Parenteral Screening Market size in 2030?

Ans: The Non-invasive Parenteral Screening Market size in 2030 will be US$ 7241.6 million.

Who are the main players in the Non-invasive Parenteral Screening Market report?

Ans: The main players in the Non-invasive Parenteral Screening Market are GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group

What are the Application segmentation covered in the Non-invasive Parenteral Screening Market report?

Ans: The Applications covered in the Non-invasive Parenteral Screening Market report are Diagnostic Laboratories, Hospitals

What are the Type segmentation covered in the Non-invasive Parenteral Screening Market report?

Ans: The Types covered in the Non-invasive Parenteral Screening Market report are Instruments, Consumables

Recommended Reports

Prenatal Diagnostics

Genetic Diagnostics

Noninvasive & Precision

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-invasive Parenteral Screening Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Instruments

1.2.3 Consumables

1.3 Market by Application

1.3.1 Global Non-invasive Parenteral Screening Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Diagnostic Laboratories

1.3.3 Hospitals

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-invasive Parenteral Screening Market Perspective (2019-2030)

2.2 Global Non-invasive Parenteral Screening Growth Trends by Region

2.2.1 Non-invasive Parenteral Screening Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-invasive Parenteral Screening Historic Market Size by Region (2019-2024)

2.2.3 Non-invasive Parenteral Screening Forecasted Market Size by Region (2025-2030)

2.3 Non-invasive Parenteral Screening Market Dynamics

2.3.1 Non-invasive Parenteral Screening Industry Trends

2.3.2 Non-invasive Parenteral Screening Market Drivers

2.3.3 Non-invasive Parenteral Screening Market Challenges

2.3.4 Non-invasive Parenteral Screening Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Non-invasive Parenteral Screening by Players

3.1.1 Global Non-invasive Parenteral Screening Revenue by Players (2019-2024)

3.1.2 Global Non-invasive Parenteral Screening Revenue Market Share by Players (2019-2024)

3.2 Global Non-invasive Parenteral Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Non-invasive Parenteral Screening, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Non-invasive Parenteral Screening Market Concentration Ratio

3.4.1 Global Non-invasive Parenteral Screening Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Revenue in 2023

3.5 Global Key Players of Non-invasive Parenteral Screening Head office and Area Served

3.6 Global Key Players of Non-invasive Parenteral Screening, Product and Application

3.7 Global Key Players of Non-invasive Parenteral Screening, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive Parenteral Screening Breakdown Data by Type

4.1 Global Non-invasive Parenteral Screening Historic Market Size by Type (2019-2024)

4.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2025-2030)

5 Non-invasive Parenteral Screening Breakdown Data by Application

5.1 Global Non-invasive Parenteral Screening Historic Market Size by Application (2019-2024)

5.2 Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-invasive Parenteral Screening Market Size (2019-2030)

6.2 North America Non-invasive Parenteral Screening Market Size by Type

6.2.1 North America Non-invasive Parenteral Screening Market Size by Type (2019-2024)

6.2.2 North America Non-invasive Parenteral Screening Market Size by Type (2025-2030)

6.2.3 North America Non-invasive Parenteral Screening Market Share by Type (2019-2030)

6.3 North America Non-invasive Parenteral Screening Market Size by Application

6.3.1 North America Non-invasive Parenteral Screening Market Size by Application (2019-2024)

6.3.2 North America Non-invasive Parenteral Screening Market Size by Application (2025-2030)

6.3.3 North America Non-invasive Parenteral Screening Market Share by Application (2019-2030)

6.4 North America Non-invasive Parenteral Screening Market Size by Country

6.4.1 North America Non-invasive Parenteral Screening Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Non-invasive Parenteral Screening Market Size by Country (2019-2024)

6.4.3 North America Non-invasive Parenteral Screening Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Non-invasive Parenteral Screening Market Size (2019-2030)

7.2 Europe Non-invasive Parenteral Screening Market Size by Type

7.2.1 Europe Non-invasive Parenteral Screening Market Size by Type (2019-2024)

7.2.2 Europe Non-invasive Parenteral Screening Market Size by Type (2025-2030)

7.2.3 Europe Non-invasive Parenteral Screening Market Share by Type (2019-2030)

7.3 Europe Non-invasive Parenteral Screening Market Size by Application

7.3.1 Europe Non-invasive Parenteral Screening Market Size by Application (2019-2024)

7.3.2 Europe Non-invasive Parenteral Screening Market Size by Application (2025-2030)

7.3.3 Europe Non-invasive Parenteral Screening Market Share by Application (2019-2030)

7.4 Europe Non-invasive Parenteral Screening Market Size by Country

7.4.1 Europe Non-invasive Parenteral Screening Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Non-invasive Parenteral Screening Market Size by Country (2019-2024)

7.4.3 Europe Non-invasive Parenteral Screening Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Non-invasive Parenteral Screening Market Size (2019-2030)

8.2 China Non-invasive Parenteral Screening Market Size by Type

8.2.1 China Non-invasive Parenteral Screening Market Size by Type (2019-2024)

8.2.2 China Non-invasive Parenteral Screening Market Size by Type (2025-2030)

8.2.3 China Non-invasive Parenteral Screening Market Share by Type (2019-2030)

8.3 China Non-invasive Parenteral Screening Market Size by Application

8.3.1 China Non-invasive Parenteral Screening Market Size by Application (2019-2024)

8.3.2 China Non-invasive Parenteral Screening Market Size by Application (2025-2030)

8.3.3 China Non-invasive Parenteral Screening Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Non-invasive Parenteral Screening Market Size (2019-2030)

9.2 Asia Non-invasive Parenteral Screening Market Size by Type

9.2.1 Asia Non-invasive Parenteral Screening Market Size by Type (2019-2024)

9.2.2 Asia Non-invasive Parenteral Screening Market Size by Type (2025-2030)

9.2.3 Asia Non-invasive Parenteral Screening Market Share by Type (2019-2030)

9.3 Asia Non-invasive Parenteral Screening Market Size by Application

9.3.1 Asia Non-invasive Parenteral Screening Market Size by Application (2019-2024)

9.3.2 Asia Non-invasive Parenteral Screening Market Size by Application (2025-2030)

9.3.3 Asia Non-invasive Parenteral Screening Market Share by Application (2019-2030)

9.4 Asia Non-invasive Parenteral Screening Market Size by Region

9.4.1 Asia Non-invasive Parenteral Screening Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Non-invasive Parenteral Screening Market Size by Region (2019-2024)

9.4.3 Asia Non-invasive Parenteral Screening Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Type

10.2.1 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Application

10.3.1 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Country

10.4.1 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 GE Healthcare

11.1.1 GE Healthcare Company Details

11.1.2 GE Healthcare Business Overview

11.1.3 GE Healthcare Non-invasive Parenteral Screening Introduction

11.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.1.5 GE Healthcare Recent Developments

11.2 Philips

11.2.1 Philips Company Details

11.2.2 Philips Business Overview

11.2.3 Philips Non-invasive Parenteral Screening Introduction

11.2.4 Philips Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.2.5 Philips Recent Developments

11.3 Illumina

11.3.1 Illumina Company Details

11.3.2 Illumina Business Overview

11.3.3 Illumina Non-invasive Parenteral Screening Introduction

11.3.4 Illumina Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.3.5 Illumina Recent Developments

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Introduction

11.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.4.5 Thermo Fisher Scientific Recent Developments

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Non-invasive Parenteral Screening Introduction

11.5.4 Roche Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.5.5 Roche Recent Developments

11.6 PacBio

11.6.1 PacBio Company Details

11.6.2 PacBio Business Overview

11.6.3 PacBio Non-invasive Parenteral Screening Introduction

11.6.4 PacBio Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.6.5 PacBio Recent Developments

11.7 Perkinelmer

11.7.1 Perkinelmer Company Details

11.7.2 Perkinelmer Business Overview

11.7.3 Perkinelmer Non-invasive Parenteral Screening Introduction

11.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.7.5 Perkinelmer Recent Developments

11.8 Qiagen

11.8.1 Qiagen Company Details

11.8.2 Qiagen Business Overview

11.8.3 Qiagen Non-invasive Parenteral Screening Introduction

11.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.8.5 Qiagen Recent Developments

11.9 Agilent Technologies

11.9.1 Agilent Technologies Company Details

11.9.2 Agilent Technologies Business Overview

11.9.3 Agilent Technologies Non-invasive Parenteral Screening Introduction

11.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.9.5 Agilent Technologies Recent Developments

11.10 BGI Group

11.10.1 BGI Group Company Details

11.10.2 BGI Group Business Overview

11.10.3 BGI Group Non-invasive Parenteral Screening Introduction

11.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Business (2019-2024)

11.10.5 BGI Group Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

GE Healthcare

Philips

Illumina Inc

Thermo Fisher Scientific

Roche

PacBio

PerkinElmer Inc

BGI Group

Qiagen

Qiagen NV

Agilent Technologies

List of Tables

Table 1. Global Non-invasive Parenteral Screening Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Instruments

Table 3. Key Players of Consumables

Table 4. Global Non-invasive Parenteral Screening Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Non-invasive Parenteral Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Non-invasive Parenteral Screening Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Non-invasive Parenteral Screening Market Share by Region (2019-2024)

Table 8. Global Non-invasive Parenteral Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Non-invasive Parenteral Screening Market Share by Region (2025-2030)

Table 10. Non-invasive Parenteral Screening Market Trends

Table 11. Non-invasive Parenteral Screening Market Drivers

Table 12. Non-invasive Parenteral Screening Market Challenges

Table 13. Non-invasive Parenteral Screening Market Restraints

Table 14. Global Non-invasive Parenteral Screening Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Non-invasive Parenteral Screening Revenue Share by Players (2019-2024)

Table 16. Global Top Non-invasive Parenteral Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening as of 2023)

Table 17. Global Non-invasive Parenteral Screening Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Non-invasive Parenteral Screening Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Non-invasive Parenteral Screening, Headquarters and Area Served

Table 20. Global Key Players of Non-invasive Parenteral Screening, Product and Application

Table 21. Global Key Players of Non-invasive Parenteral Screening, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-invasive Parenteral Screening Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2019-2024)

Table 25. Global Non-invasive Parenteral Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Non-invasive Parenteral Screening Revenue Market Share by Type (2025-2030)

Table 27. Global Non-invasive Parenteral Screening Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Non-invasive Parenteral Screening Revenue Share by Application (2019-2024)

Table 29. Global Non-invasive Parenteral Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Non-invasive Parenteral Screening Revenue Share by Application (2025-2030)

Table 31. North America Non-invasive Parenteral Screening Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Non-invasive Parenteral Screening Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Non-invasive Parenteral Screening Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Non-invasive Parenteral Screening Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Non-invasive Parenteral Screening Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Non-invasive Parenteral Screening Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Non-invasive Parenteral Screening Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Non-invasive Parenteral Screening Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Non-invasive Parenteral Screening Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Non-invasive Parenteral Screening Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Non-invasive Parenteral Screening Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Non-invasive Parenteral Screening Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Non-invasive Parenteral Screening Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Non-invasive Parenteral Screening Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Non-invasive Parenteral Screening Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Non-invasive Parenteral Screening Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Non-invasive Parenteral Screening Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Non-invasive Parenteral Screening Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Non-invasive Parenteral Screening Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Non-invasive Parenteral Screening Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Non-invasive Parenteral Screening Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Non-invasive Parenteral Screening Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Non-invasive Parenteral Screening Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Non-invasive Parenteral Screening Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Non-invasive Parenteral Screening Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size by Country (2025-2030) & (US$ Million)

Table 63. GE Healthcare Company Details

Table 64. GE Healthcare Business Overview

Table 65. GE Healthcare Non-invasive Parenteral Screening Product

Table 66. GE Healthcare Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 67. GE Healthcare Recent Developments

Table 68. Philips Company Details

Table 69. Philips Business Overview

Table 70. Philips Non-invasive Parenteral Screening Product

Table 71. Philips Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 72. Philips Recent Developments

Table 73. Illumina Company Details

Table 74. Illumina Business Overview

Table 75. Illumina Non-invasive Parenteral Screening Product

Table 76. Illumina Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 77. Illumina Recent Developments

Table 78. Thermo Fisher Scientific Company Details

Table 79. Thermo Fisher Scientific Business Overview

Table 80. Thermo Fisher Scientific Non-invasive Parenteral Screening Product

Table 81. Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 82. Thermo Fisher Scientific Recent Developments

Table 83. Roche Company Details

Table 84. Roche Business Overview

Table 85. Roche Non-invasive Parenteral Screening Product

Table 86. Roche Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 87. Roche Recent Developments

Table 88. PacBio Company Details

Table 89. PacBio Business Overview

Table 90. PacBio Non-invasive Parenteral Screening Product

Table 91. PacBio Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 92. PacBio Recent Developments

Table 93. Perkinelmer Company Details

Table 94. Perkinelmer Business Overview

Table 95. Perkinelmer Non-invasive Parenteral Screening Product

Table 96. Perkinelmer Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 97. Perkinelmer Recent Developments

Table 98. Qiagen Company Details

Table 99. Qiagen Business Overview

Table 100. Qiagen Non-invasive Parenteral Screening Product

Table 101. Qiagen Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 102. Qiagen Recent Developments

Table 103. Agilent Technologies Company Details

Table 104. Agilent Technologies Business Overview

Table 105. Agilent Technologies Non-invasive Parenteral Screening Product

Table 106. Agilent Technologies Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 107. Agilent Technologies Recent Developments

Table 108. BGI Group Company Details

Table 109. BGI Group Business Overview

Table 110. BGI Group Non-invasive Parenteral Screening Product

Table 111. BGI Group Revenue in Non-invasive Parenteral Screening Business (2019-2024) & (US$ Million)

Table 112. BGI Group Recent Developments

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-invasive Parenteral Screening Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Non-invasive Parenteral Screening Market Share by Type: 2023 VS 2030

Figure 3. Instruments Features

Figure 4. Consumables Features

Figure 5. Global Non-invasive Parenteral Screening Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Non-invasive Parenteral Screening Market Share by Application: 2023 VS 2030

Figure 7. Diagnostic Laboratories Case Studies

Figure 8. Hospitals Case Studies

Figure 9. Non-invasive Parenteral Screening Report Years Considered

Figure 10. Global Non-invasive Parenteral Screening Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Non-invasive Parenteral Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Non-invasive Parenteral Screening Market Share by Region: 2023 VS 2030

Figure 13. Global Non-invasive Parenteral Screening Market Share by Players in 2023

Figure 14. Global Top Non-invasive Parenteral Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Non-invasive Parenteral Screening Revenue in 2023

Figure 16. North America Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Non-invasive Parenteral Screening Market Share by Type (2019-2030)

Figure 18. North America Non-invasive Parenteral Screening Market Share by Application (2019-2030)

Figure 19. North America Non-invasive Parenteral Screening Market Share by Country (2019-2030)

Figure 20. United States Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Non-invasive Parenteral Screening Market Size YoY (2019-2030) & (US$ Million)

Figure 23. Europe Non-invasive Parenteral Screening Market Share by Type (2019-2030)

Figure 24. Europe Non-invasive Parenteral Screening Market Share by Application (2019-2030)

Figure 25. Europe Non-invasive Parenteral Screening Market Share by Country (2019-2030)

Figure 26. Germany Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. China Non-invasive Parenteral Screening Market Size YoY (2019-2030) & (US$ Million)

Figure 33. China Non-invasive Parenteral Screening Market Share by Type (2019-2030)

Figure 34. China Non-invasive Parenteral Screening Market Share by Application (2019-2030)

Figure 35. Asia Non-invasive Parenteral Screening Market Size YoY (2019-2030) & (US$ Million)

Figure 36. Asia Non-invasive Parenteral Screening Market Share by Type (2019-2030)

Figure 37. Asia Non-invasive Parenteral Screening Market Share by Application (2019-2030)

Figure 38. Asia Non-invasive Parenteral Screening Market Share by Region (2019-2030)

Figure 39. Japan Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. China Taiwan Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. India Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Australia Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Size YoY (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Share by Type (2019-2030)

Figure 47. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Share by Application (2019-2030)

Figure 48. Middle East, Africa, and Latin America Non-invasive Parenteral Screening Market Share by Country (2019-2030)

Figure 49. Brazil Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Mexico Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Turkey Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Israel Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. GCC Countries Non-invasive Parenteral Screening Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 56. Philips Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 57. Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 59. Roche Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 60. PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 61. Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 62. Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 63. Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 64. BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Non Invasive Prenatal Testing Devices Market Insights Forecast to 2030

Global Non Invasive Prenatal Screening NIPS Market Research Report 2024

Global NIPT NIPS Testing Service Market Research Report 2024

Non Invasive Prenatal Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Noninvasive Prenatal Testing Service Market Research Report 2025

Global Microarray based Non Invasive Prenatal Testing Market Research Report 2024

Global Non Invasive Prenatal DNA Testing Service Market Research Report 2024

Non invasive Prenatal Testing Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Invasive Prenatal Testing Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Invasive Prenatal Testing NIPT Market Research Report 2024

Global Prenatal Genetic Screening Test Market Research Report 2024

Global Non invasive Preimplantation Genetic Testing Market Research Report 2024

Medical Newborn Screening Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prenatal Testing and Newborn Screening Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2024

Global Newborn and Prenatal Genetic Testing Market Insights Forecast to 2030

Global Non invasive Prenatal Paternity Testing NIPPT Market Research Report 2024

Global Non Invasive Cancer Detection Market Research Report 2024

Noninvasive Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions